PHGE vs REGN: Which Stock is Better?
Side-by-side comparison of Biomx Inc and Regeneron Pharmaceuticals Inc in 2026
PHGE
Biomx Inc
$1.13
REGN
Regeneron Pharmaceuticals Inc
$751.57
Key Metrics Comparison
| Metric | PHGE | REGN | Winner |
|---|---|---|---|
| Market Cap | $10.52M | $80.98B | REGN |
| P/E Ratio | N/A | 18.45 | REGN |
| EPS (TTM) | $N/A | $41.51 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze PHGE
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHGE or REGN a better investment?
Comparing PHGE and REGN: Biomx Inc has a market cap of $10.52M while Regeneron Pharmaceuticals Inc has $80.98B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHGE and REGN?
PHGE (Biomx Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHGE or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHGE or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for PHGE.
Which company is more profitable: PHGE or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for PHGE.
Which is the larger company: PHGE or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $80.98B compared to $10.52M for PHGE.
Should I buy PHGE or REGN in 2026?
Both PHGE and REGN have investment merit. PHGE trades at $1.13 while REGN trades at $751.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHGE and REGN stock?
Key differences: Market Cap ($10.52M vs $80.98B), P/E Ratio (N/A vs 18.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).